Search Results (542)

The precise fabrication and controllable actuation of magnetic microspheres hold significant application value in biomedicine, microfluidic chips and other fields. Based on femtosecond laser two-photon polymerization technology (FLTPP), two methods are adopted to prepare magnetic microspheres in this study. Magnetic microspheres are fabricated via photoresist modification and post-treatment processes. Meanwhile, a 3D magnetic actuation system composed of a three-axis movable magnetic drive module and a real-time imaging system is constructed, enabling the flexible 3D actuation and real-time dynamic monitoring and visualized observation of magnetic microspheres. The results demonstrate that the magnetic microspheres exhibit sensitive magnetic response characteristics. The constructed magnetic actuation system features large travel range (XY: ±6.5 mm, Z: 10 mm), high precision (20 μm) and flexible manipulation, enabling stable locomotion of the microrobots in straight channels, L-shaped channels, and square channels. This study provides a technical reference for the fabrication and manipulation of magnetic micro/nano devices, and lays a foundation for their subsequent integrated applications in microfluidic systems. Full article

Translating preclinical findings into effective clinical cancer immunotherapies remains a major challenge, mainly because conventional in vitro and animal models often fail to capture the complexity, dynamics, and species-specific features of human immune responses. Organ-on-a-chip (OoC) technologies that combine engineered tissue architectures with precisely controlled microfluidic transport provide human-relevant microphysiological platforms for mechanistic studies of immune–tumor interactions and evaluation of therapeutic efficacy and immunotoxicity under defined microenvironmental conditions. However, immune responses involve time-dependent and interconnected processes, including immune cell trafficking, cytokine programs, metabolic shifts, and cytolysis, that are not adequately resolved by static or endpoint assays. Engineering immune-competent OoC systems therefore requires coordinated design of platform architectures, immune cell incorporation strategies, and integrated measurement workflows capable of capturing dynamic and state-dependent responses. In this review, we summarize engineering strategies for building immune-competent OoC platforms for cancer immunotherapy, focusing on platform architectures, immune cell incorporation methods, and fit-for-purpose assay workflows. Emphasis is placed on embedded sensing modalities (e.g., cytokine, oxygen, and impedance readouts) that provide valuable kinetic and state-variable data. Finally, we discuss key translational challenges, including reproducibility, standardization, and benchmarking, and outline near-term priorities to accelerate the adoption of immune-competent OoC systems in immunotherapy research and development. Full article

Microbial contamination in aquatic environments poses severe threats to aquaculture sustainability, ecological balance and public health. Traditional culture-based detection methods, while standardized, are time-consuming and labor-intensive, often failing to meet the urgent need for rapid on-site monitoring required to prevent disease outbreaks and manage water quality effectively. By integrating latest research advances (2020–2025), this study reviews advances in rapid detection technologies for aquatic microorganisms, including the evolution of nucleic acid amplification strategies, with a focused comparison of the analytical sensitivity and field deployability of quantitative polymerase chain reaction (qPCR) and mainstream isothermal amplification techniques (loop-mediated isothermal amplification, LAMP; recombinase polymerase amplification, RPA). Furthermore, this study reports on the emergence of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated protein (Cas) systems as next-generation diagnostic tools, highlighting their integration with microfluidic Lab-on-a-Chip (LOC) platforms to achieve attomolar sensitivity. We also consider the application of portable nanopore sequencing for real-time pathogen identification and the growing role of Artificial Intelligence (AI) in analyzing complex diagnostic datasets. Advanced molecular methods have achieved significant reductions in time consumption—from days to less than one hour—while challenges regarding sample preparation and environmental matrix inhibition remain. The future of aquatic monitoring lies in integrated, automated systems that combine the specificity of CRISPR-Cas diagnostics with the connectivity of IoT-enabled biosensors. Comparative analysis indicates that isothermal amplification methods (LAMP, RPA) coupled with CRISPR-Cas systems offer the optimal balance of sensitivity, speed, and field deployability for point-of-care aquaculture diagnostics, while qPCR/dPCR remain indispensable for quantitative regulatory applications. We propose a structured technology selection framework to guide researchers and practitioners in choosing appropriate detection modalities based on specific sensitivity, cost, throughput, and deployment requirements. Full article

Microorganisms represent the Earth’s most abundant biomass and a vast reservoir of genetic diversity. However, traditional agar plate methods fail to recover the vast majority of these species, leaving a “microbial dark matter” that holds immense potential for the discovery of novel antibiotics and bioactive compounds. While conventional techniques such as selective media and enrichment culture remain foundational, they are inherently limited by community biases and the inability to support low-abundance, oligotrophic species. To address these bottlenecks, a diverse array of innovative isolation strategies has emerged. This review systematically categorizes and evaluates these methodologies, ranging from in situ cultivation to high-resolution single-cell manipulation. We first examine membrane diffusion-based cultivation (e.g., iChip), which mimics natural microenvironments to resuscitate recalcitrant microbes. Subsequently, we explore high-throughput single-cell technologies, including microfluidics for physicochemical separation, optical tweezers for precise manipulation, and fluorescence-activated cell sorting (FACS). Special attention is given to Raman-activated cell sorting (RACS) as a label-free functional screening tool and reverse genomics for targeted capture. By synthesizing the strengths and limitations of these approaches, we propose integrated workflows designed to accelerate the mining of untapped microbial resources. Full article

Microfluidic electrokinetic flows play a central role in applications such as lab-on-a-chip diagnostics, microelectronics cooling, and biomedical sample manipulation. These systems involve intricate heat transfer processes, including Joule heating from ionic currents, temperature-driven flow instabilities, and coupled thermal–fluid interactions, that crucially affect device performance, reliability, and scalability. Current challenges include non-equilibrium charge dynamics, incomplete thermophysical property data for complex fluids, and thermal crosstalk in integrated platforms. This review summarizes the literature published over the past 20 years, with occasional reference to earlier work, covering the fundamental mechanisms of heat generation and dissipation in electrokinetic microflows; analytical, numerical, and experimental approaches for characterizing thermal effects; and discussion on the limitations and application-driven opportunities. It also highlights open questions and future research directions and offers a comprehensive view of design principles and guidelines for developing robust, thermally optimized electrokinetic microfluidic technologies. Full article

Central nervous system (CNS) disorders represent a growing healthcare burden, and various drugs are developed for their treatment. However, the blood–brain barrier (BBB) prevents over 98% of therapeutics from reaching brain tissue. Intranasal delivery provides a promising alternative by exploiting olfactory and trigeminal nerve pathways to circumvent the BBB. This review surveys recent advances in nose-to-brain delivery technologies, from carrier design to evaluation methods. Polymeric and lipid-based nanocarriers show enhanced mucosal penetration and prolonged residence time, and microneedle platforms further enable controlled drug release with minimal discomfort. To evaluate these delivery strategies, sensor-integrated organ-on-chip models provide more physiologically relevant testing than static cultures. Although persistent challenges such as rapid mucociliary clearance and formulation stability remain, combining nanotechnology with microfluidic devices and computational modeling shows potential for developing patient-specific therapeutics. Full article

Surface Acoustic Wave (SAW) technology, long central to analog signal processing and RF filtering, is undergoing a major renewal. Driven by advances that decouple SAWs from traditional piezoelectric materials and fixed-function devices, the field is gaining unprecedented control over acoustic, optical, and electronic interactions at the micro and nanoscale. This review synthesizes these developments across four fronts: new physical mechanisms for SAW manipulation, emerging material platforms, ranging from thin films to 2D systems, along with reconfigurable device architectures and circuits, and the expanding landscape of applications they enable. Optical methods are reshaping how SAWs are generated and controlled, bypassing the limits of conventional electromechanical coupling. Coherent optical excitation of high-Q SAW cavities via Brillouin-like optomechanical interactions now grants access to modes in non-piezoelectric substrates such as diamond and silicon, while on-chip SAW excitation in photonic waveguides through backward stimulated Brillouin scattering opens new integrated sensing routes. In parallel, magneto-acoustic experiments have revealed nonreciprocal SAW diffraction from resonant scattering in magnetoelastic gratings. On the device side, ZnO thin-film transistors integrated on LiNbO₃ exploit acoustoelectric coupling to realize voltage-tunable phase shifters; UHF Z-shaped delay lines achieve high sensitivity in a compact footprint; and parametric synthesis of wideband, multi-stage lattice filters targets 5G-class performance. Atomistic simulations show that SAW propagation in 2D MXene films can be engineered via surface terminations, while aerosol jet printing and SAW-assisted particle patterning provide agile, cleanroom-light fabrication of microfluidic and magnetic components. These advances enable applications ranging from hybrid quantum systems and quantum links to lab-on-a-chip particle control, SBS-based and UHF sensing, reconfigurable RF front-ends, and soft robotic actuators based on patterned magnetic composites. At the same time, optical techniques offer non-contact probes of dissipation, and MXenes and other emerging materials open new regimes of acoustic control. Conclusively, they are transforming SAW technology into a versatile, programmable platform for mediating complex interactions in next-generation electronic, photonic, and quantum systems. Full article

Precise manipulation and directed transport of micro- and nano-particles are cornerstones of emerging lab-on-a-chip technologies. Traditional optofluidic systems that combine optical tweezers with microfluidic channels enable long-range transport. However, they rely on fixed physical boundaries that lack reconfigurability. To bridge this gap, we propose a reconfigurable virtual optical waveguide (VOW) based on a discretized beam-shaping strategy. By superposing two orthogonally polarized shaped beams, we construct interference-free optical channels without physical boundaries. This platform enables programmable transport along complex trajectories, including space-filling Hilbert curves that maximize interaction path length, and shields the transport channel from perturbations induced by surrounding particles. Crucially, the VOW offers multi-dimensional sorting capabilities: (i) it performs precise size-dependent sieving via tunable channel widths, and (ii) it functions as an intrinsic material filter by stably guiding scattering-dominated particles (e.g., gold) while rejecting gradient-dominated dielectric ones. This work establishes a versatile, contactless strategy for adaptive optical logistics and on-chip material purification. Full article

The development of high-throughput technologies for the separation and labeling of extracellular vesicles (EVs) from whole blood is critical for downstream EV detection and analysis. However, conventional EV separation and labeling workflows are typically labor-intensive and inefficient, requiring multiple sequential processing steps. Here, we present a microfluidic platform that integrates negative magnetophoresis-based separation with mixing-enhanced on-chip labeling. The chip adopts a vertical flow channel architecture in combination with a Halbach-array magnetic field configuration, thereby overcoming the throughput limitations inherent to traditional horizontal microchannels. Parallel channels can be freely arranged above on the magnetic array to achieve ultra-high throughput processing, achieving a cell removal efficiency of 99.97% at a blood-to-sheath flow ratio of 1:5. Furthermore, by incorporating a narrow-wide channel design synergized with a herringbone–Tesla micromixer structure, the platform achieves a labeling efficiency of 91.8% within 2 min, approaching the performance of conventional 20 min incubation. This system offers both high-throughput and integration capabilities, providing a powerful technical platform for EV-related life science research. Full article

Cell-based immuno-biosensors are novel platforms for studying immune responses of biological cells, with real-time insights more similar to physiological and pathological conditions. These systems utilize living immune cells as their main components, enabling them to detect disease-related biomarkers and cellular traits in a way that is often highly sensitive and label-free. Integration with microfluidics and organ-on-chip technologies has facilitated precise manipulational control over the cellular microenvironment. Not only has this resulted in high-throughput screening, but it also enabled smaller, more portable systems which can be used at the point of care. In this work, we review the recent advance in microfluidic cell-based immuno-biosensing associated with immune cells such as neutrophils, macrophages, T cell and dendrite cells. Some of the exciting developments include fusion with methods such as advanced imaging, electrical impedance sensing and application of machine learning to phenotyping. We will also elaborate on the issues related to the standardization of these systems, cell heterogeneity, and the challenges for translating these technologies for clinical application. Taken together, such integrated platforms have potential to fill the gap left in-between cellular immunology with biosensor engineering. Full article

Additive Manufacturing (AM) and Wearable Technologies (WT) have rapidly evolved over the past decade. AM offers highly customisable fabrication, while WT enables minimally invasive health monitoring. The intersection of these fields presents emerging opportunities in biomedical and engineering domains. This study aims to map the scientific landscape of AM–WT research between 2015 and 2025 through a comprehensive bibliometric analysis. A total of 718 peer-reviewed publications were extracted from Web of Science (WoS), Scopus, and PubMed, following PRISMA-ScR guidelines. Using RStudio and the Bibliometrix package, analyses included co-authorship, citation trends, keyword co-occurrence, and thematic mapping. Custom author disambiguation scripts enhanced data quality and reliability. An annual publication growth of 24.89% was observed, with notable increases after 2020. Core themes included 3D printing, biosensors, microfluidics, and organ-on-a-chip devices. A shift from manufacturing-oriented research to biomedical integration is evident. Research output is dominated by the US, China, and South Korea, with moderate but not yet highly internationalised collaboration. The field of AM–WT research is undergoing a decisive transition from fabrication-focused studies to interdisciplinary, application-driven innovations. This shift is marked by increasing integration in healthcare and bioelectronics, yet hindered by regional imbalances and thematic gaps. Addressing these will be critical to advancing global impact. This study offers a cross-database bibliometric overview of AM–WT research. By combining three major data sources, it provides enhanced coverage and introduces novel analytical dimensions to guide future interdisciplinary efforts in personalised healthcare and wearable device innovation. Full article

Lab-on-a-Chip (LoC) and microfluidic technologies are rapidly reshaping the development pipeline for nano drug delivery systems (DDSs) by enabling precise control of physicochemical properties, high-throughput screening, and integrated biological evaluation within miniaturized platforms. This review synthesizes recent advances in microfluidic principles, fabrication strategies, and sensing modalities that facilitate continuous flow synthesis, real-time characterization, and adaptive formulation of nanoparticles. We highlight how LoC-enabled systems improve monodispersity, reproducibility, and tunability of liposomes, polymeric nanoparticles, and metallic nanocarriers, while providing powerful tools for assessing pharmacokinetics, drug release, and systemic responses using organ-on-chip (OoC) models. Emerging trends, including AI-driven autonomous optimization, stimuli-responsive materials, 3D-printed hybrid architectures, and self-powered portable devices, are discussed in the context of future integrated nano-pharmaceutics platforms. Despite existing challenges related to biocompatibility, standardization, data integration, and translation to industrial and clinical applications, the synergistic evolution of LoC engineering and nanomedicine holds transformative potential for personalized and next-generation therapeutic strategies. Full article

Bone is a dynamic and multifunctional tissue that provides mechanical support, regulates mineral homeostasis, supports hematopoiesis, and relies on complex interactions among multiple cell types. The increasing incidence of bone-related diseases, such as osteoporosis, osteoarthritis, fracture non-union, and bone cancer, highlights the need for in vitro models that better reflect human bone physiology. Bone-on-a-chip technology, developed through advances in microfluidics, biomaterials, and tissue engineering, offers a promising approach to recreate key features of the bone microenvironment in vitro. By incorporating bone-mimicking materials, relevant bone cells, vascular components, fluid perfusion, and mechanical stimulation, these platforms allow more realistic investigation of bone remodeling, regeneration, disease mechanisms, and drug responses. In parallel, bone organoids and their integration with microfluidic chips have further expanded the capabilities of in vitro bone models by enabling the formation of self-organized, human-relevant bone tissues with increased cellular complexity. This review summarizes recent progress in bone-on-a-chip systems, including models for osteogenesis and bone regeneration, vascularized bone, bone marrow and hematopoietic niches, cancer bone metastasis, and mechanobiological studies. Key design principles, materials, cellular components, and applications in disease modeling, drug screening, toxicity assessment, and personalized medicine are discussed. Current challenges and future directions are also discussed to support the continued development of more physiologically relevant in vitro bone models. Full article

Implantable artificial kidneys represent a promising alternative for patients with end-stage renal disease (ESRD), aiming to overcome the limitations of conventional dialysis through the integration of microfluidic and electrokinetic technologies. In this study, we present a sawtooth electrode microfluidic chamber that achieves blood cell separation via negative dielectrophoresis at a record-low operating voltage of 1.4 V, representing a fivefold reduction compared with rectangular electrode designs and supporting potential integration into implantable artificial kidney systems. A microfluidic chip incorporating an asymmetric sawtooth electrode geometry was developed to enhance local electric field gradients while reducing power consumption. Device performance was investigated using COMSOL Multiphysics simulations. Response Surface Methodology (RSM) based on a Box–Behnken design was employed to optimize the number of teeth per unit length (N), sawtooth height (H), and applied voltage (V), while excitation frequency was fixed at 1 MHz and flow velocity was maintained constant at 0.1 µL·min⁻¹. Statistical analysis was conducted using analysis of variance (ANOVA) in Minitab (Version 27; Minitab, LLC, State College, PA, USA, 2024). The optimization model showed strong predictive capability (R² = 95.8%) and identified applied voltage (59.45% contribution) and sawtooth height (33%) as the dominant factors affecting separation efficiency, with a significant H × V interaction (p = 0.023). Comprehensive voltage-response mapping over the range of 0.8–4.0 V revealed four operational regimes, including a previously unreported high-voltage failure zone above 2.8 V, where electrothermal flow and electroporation degrade performance. Under physiological conductivity conditions, the optimized design maintained a separation efficiency of 78.3% at 1.4 V with a tip temperature rise of only 1.2 °C, while full recovery of performance was achieved at 2.2 V. Cell-specific separation efficiencies reached 97.3% for white blood cells, 95.8% for red blood cells, and 84.7% for platelets, reducing the downstream cellular load by 92.6%. These findings demonstrate that the proposed low-voltage, high-efficiency separation platform has strong potential as a cellular pre-filtration module in implantable artificial kidney systems and other lab-on-chip biomedical devices. Full article

Organ-on-a-chip (OoC) technologies, also termed microphysiological systems (MPSs), integrate microfluidics, engineered biomaterials, human-derived cells, and on-chip biosensing to model human physiology in microscale devices that deliver quantitative, time-resolved readouts. This review surveys the 2010–2025 literature, emphasizing how sensing, standardized sampling, and analytics enable clinical concordance and fit-for-purpose regulatory use. We synthesize advances in (i) materials, fabrication, and microfluidic design; (ii) organ- and disease-focused case studies; and (iii) translational benchmarks that align chip outputs with clinical pharmacokinetics, toxicology, and biomarker datasets. Across organ systems, platforms increasingly incorporate vascularization, immune components, and organoid hybrids, paired with real-time measurements of barrier integrity, metabolism, electrophysiology, and secreted biomarkers using impedance (TEER), electrochemical, and optical modalities. Representative benchmarking studies report cardiac OoCs achieving AUROC ≥ 0.85 for torsadogenic risk classification, and renal chips improving prediction of transporter-mediated clearance relative to conventional in vitro assays. We summarize validation approaches and regulatory developments relevant to new approach methodologies, including the FDA Modernization Act 2.0, and discuss how AI and multi-omics can automate signal and image analysis, harmonize cross-platform datasets, and support digital-twin workflows that couple OoC measurements to in silico models. Overall, biosensor-enabled OoCs are progressing toward quantitatively benchmarked platforms for safety pharmacology, ADME/PK–PD, and precision medicine. Full article